keyword
https://read.qxmd.com/read/38436690/-conservative-treatment-of-valvular-heart-disease-in-adults
#21
REVIEW
Johannes Kirchner, Tanja K Rudolph
Currently, there is no specific medication approved for the treatment of valvular heart disease per se. Except for secondary mitral valve insufficiency and tricuspid valve insufficiency in pulmonary hypertension, drug therapy for higher-grade valvular heart disease is limited to diuretic therapy for symptom control. Conservative therapy for comorbidities and potential heart failure can be beneficial regardless of the specific valve lesion. In cases of aortic valve stenosis or insufficiency, controlling arterial hypertension is important...
March 4, 2024: Inn Med (Heidelb)
https://read.qxmd.com/read/38432770/transcatheter-treatment-of-mitral-valve-regurgitation-in-the-setting-of-concomitant-coronary-or-multivalvular-heart-disease-a-focused-review
#22
REVIEW
Jay Ramsay, Yicheng Tang, Jin Kyung Kim, Antonio H Frangieh
Treatment for mixed valve disease has historically been limited, often surgery being the only option. With the recent advancement of transcatheter therapies, percutaneous approaches are quickly becoming viable therapeutic considerations in inoperable or high-risk patients, also offering the option for a staged or same-session treatment. Guidelines are primarily focused on single-valve disease. However, patients often present with multiple pathologies. This review summarizes the data and literature on transcatheter treatment of patients with mitral regurgitation who concomitantly have aortic stenosis or regurgitation, tricuspid regurgitation, or ischemic cardiomyopathy...
April 2024: Interventional Cardiology Clinics
https://read.qxmd.com/read/38412895/transfemoral-transcatheter-aortic-valve-replacement-with-vitaflow-tm-valve-for-pure-native-aortic-regurgitation-in-patients-with-high-surgical-risk-rationale-and-design-of-a-prospective-multicenter-and-randomized-season-ar-trial
#23
JOURNAL ARTICLE
Juan Zhang, Xiang-Quan Kong, Xiao-Fei Gao, Jing Chen, Xiang Chen, Bo Li, Yi-Bing Shao, Yan Wang, Hong Jiang, Jian-Cheng Zhu, Jun-Jie Zhang, Shao-Liang Chen
BACKGROUND: Previous studies primarily demonstrated that transfemoral transcatheter aortic valve replacement (TAVR) with self-expanding valve appeared to be a safe and feasible treatment for patients with pure native aortic regurgitation (AR). However, the routine application of transfemoral TAVR for pure AR patients lacks support from randomized trials. TRIAL DESIGN: SEASON-AR trial is a prospective, multicenter, randomized, controlled, parallel-group, open-label trial, involving at least 20 sites in China, aiming to enroll 210 patients with pure native severe AR and high surgical risk...
February 25, 2024: American Heart Journal
https://read.qxmd.com/read/38404057/right-anterior-mini-thoracotomy-aortic-valve-replacement-versus-transcatheter-aortic-valve-implantation-in-octogenarians-a-single-center-experience-a-retrospective-study
#24
JOURNAL ARTICLE
Ji Eun Im, Eun Yeung Jung, Seok Soo Lee, Ho-Ki Min
BACKGROUND: The aim of this study was to compare the early outcomes of octogenarians undergoing minimally invasive right anterior mini-thoracotomy aortic valve replacement (RAT-AVR) with those undergoing transcatheter aortic valve implantation (TAVI) for aortic valve disease. METHODS: In this single-center retrospective study, data were collected from octogenarians before and after RAT-AVR and TAVI between January 2021 and July 2022. Short-term outcomes, including the length of hospital stay, in-hospital mortality, all-cause mortality, and other major postoperative complications, were compared and analyzed...
February 26, 2024: J Yeungnam Med Sci
https://read.qxmd.com/read/38403770/severe-left-main-coronary-artery-stenosis-and-aortic-regurgitation-in-a-patient-presenting-with-takayasu-arteritis
#25
JOURNAL ARTICLE
Akiko Tanihata, Atsushi Shibata, Kazutoshi Teragaki, Toshitake Yoshida, Ryoko Kitada, Akimasa Morisaki, Asahiro Ito, Yasuhiro Izumiya, Daiju Fukuda
We herein report the case of a 46-year-old woman with Takayasu arteritis (TA), severe stenosis in the left main coronary artery (LMCA), and severe aortic regurgitation. Prednisolone and tacrolimus were initiated as TA treatments. Two months after initiating medical therapy, the aortic regurgitation severity improved to a moderate grade, although there was no obvious improvement in LMCA stenosis. Thus, after confirming the resolution of inflammation, we performed coronary artery bypass grafting alone without any aortic valve intervention...
February 26, 2024: Internal Medicine
https://read.qxmd.com/read/38357507/libman-sacks-endocarditis-in-a-child-with-systemic-lupus-erythematosus-a-case-report-and-literature-review
#26
Jingyi Lu, Shengfang Bao, Xuemei Xu, Yingying Jin, Chenxi Liu, Yuqi Zhang, Qian Wang, Yanliang Jin
Libman-Sacks endocarditis (LSE) is a cardiac condition characterized by the growth of verrucous vegetation. Although relatively rare in children, LSE is nevertheless a known cardiac manifestation of autoimmune diseases, including systemic lupus erythematosus (SLE). The mitral valve is the most commonly affected region, followed by the aortic valve, while the tricuspid and pulmonary valves are rarely affected. The management of established Libman-Sacks vegetation poses significant challenges, often necessitating surgical interventions, although surgery is not the primary treatment modality...
2024: Frontiers in Pediatrics
https://read.qxmd.com/read/38341820/a-fast-in-silico-model-for-preoperative-risk-assessment-of-paravalvular-leakage
#27
JOURNAL ARTICLE
Michelle Spanjaards, Finja Borowski, Laura Supp, René Ubachs, Valentina Lavezzo, Olaf van der Sluis
In silico simulations can be used to evaluate and optimize the safety, quality, efficacy and applicability of medical devices. Furthermore, in silico modeling is a powerful tool in therapy planning to optimally tailor treatment for each patient. For this purpose, a workflow to perform fast preoperative risk assessment of paravalvular leakage (PVL) after transcatheter aortic valve replacement (TAVR) is presented in this paper. To this end, a novel, efficient method is introduced to calculate the regurgitant volume in a simplified, but sufficiently accurate manner...
February 11, 2024: Biomechanics and Modeling in Mechanobiology
https://read.qxmd.com/read/38340102/national-variation-in-hospital-mteer%C3%A2-outcomes-and-correlation-with%C3%A2-tavr-outcomes-sts-acc-tvt-registry-analysis
#28
JOURNAL ARTICLE
Dharam J Kumbhani, Pratik Manandhar, Anthony A Bavry, Adnan K Chhatriwalla, Jay Giri, Michael Mack, John Carroll, Ambarish Pandey, Andrzej Kosinski, Eric D Peterson, Tsuyoshi Kaneko, James A de Lemos, Sreekanth Vemulapalli
BACKGROUND: A single, multitiered valve center designation has been proposed to publicly identify centers with expertise for all valve therapies. The correlation between transcatheter aortic valve replacement (TAVR) and mitral transcatheter edge-to-edge repair (MTEER) procedures is unknown. OBJECTIVES: We sought to examine the relationship between site-level volumes and outcomes for TAVR and MTEER. We further explored variability between sites for MTEER outcomes...
January 30, 2024: JACC. Cardiovascular Interventions
https://read.qxmd.com/read/38335375/total-arch-replacement-via-single-upper-hemisternotomy-approach-for-aortic-aneurysm-in-syphilis-case-report
#29
JOURNAL ARTICLE
Lin Xia, Zhonglu Yang, Yu Liu, Yuguang Ge, Lu Wang, Hui Jiang
RATIONALE: Syphilitic aortic aneurysm is a relatively rare type of cardiovascular syphilis. A small number of patients with syphilitic aortic aneurysms will be accompanied by aortic regurgitation and coronary stenosis. Apart from aortic rupture or dissection, syphilitic aortic aneurysm often causes associated vascular disorders, including left common carotid artery, innominate artery, and celiac artery stenosis or obstruction. PATIENT CONCERNS: In this case, we observed left common carotid artery occlusion based on both ultrasound and intraoperative exploration...
February 9, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38328601/early-use-of-intrapartum-intra-aortic-balloon-pump-support-for-haemodynamic-stabilization-of-peripartum-and-anthracycline-induced-cardiomyopathy-a-case-report
#30
Karthic Chandran, Donald Quimby, Hiram G Bezerra, Daniela Crousillat
BACKGROUND: Prior exposure to cardiotoxic cancer therapies has been associated with an increased risk of peripartum cardiomyopathy (PPCM). The management of PPCM in this population remains a clinical challenge. Few studies have explored the use of mechanical circulatory support in PPCM. We present a case of early implementation of intra-aortic balloon pump (IABP) therapy for acute stabilization and intrapartum support of PPCM. CASE SUMMARY: A 36-year-old G4P2103 (4th pregnancy, two full-term, one premature birth, 0 abortions, and three living children) woman at 26 weeks and 5 days gestation with history of combined peripartum and anthracycline-induced cardiomyopathy [previously left ventricular ejection fraction (LVEF) 10-15% and recently 40-45%] presented with acute decompensated heart failure...
February 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38313286/gm1-gangliosidosis-type-ii-results-of-a-10-year-prospective-study
#31
Precilla D'Souza, Cristan Farmer, Jean Johnston, Sangwoo T Han, David Adams, Adam L Hartman, Wadih Zein, Laryssa A Huryn, Beth Solomon, Kelly King, Christopher Jordan, Jennifer Myles, Elena-Raluca Nicoli, Caroline E Rothermel, Yoliann Mojica Algarin, Reyna Huang, Rachel Quimby, Mosufa Zainab, Sarah Bowden, Anna Crowell, Ashura Buckley, Carmen Brewer, Deborah Regier, Brian Brooks, Eva Baker, Gilbert Vézina, Audrey Thurm, Cynthia J Tifft
PURPOSE: GM1 gangliosidosis (GM1) is an ultra-rare lysosomal storage disease caused by pathogenic variants in galactosidase beta 1 ( GLB1 ; NM_000404), primarily characterized by neurodegeneration, often in children. There are no approved treatments for GM1, but clinical trials using gene therapy ( NCT03952637 , NCT04713475 ) and small molecule substrate inhibitors ( NCT04221451 ) are ongoing. Understanding the natural history of GM1 is essential for timely diagnosis, facilitating better supportive care, and contextualizing the results of therapeutic trials...
January 4, 2024: medRxiv
https://read.qxmd.com/read/38236149/mixed-aortic-valve-disease-association-with-paravalvular-leak-and-reduced-survival-after-tavr
#32
JOURNAL ARTICLE
Caglayan Demirel, Max Paul Winter, Christian Nitsche, Sophia Koschatko, Charlotte Jantsch, Katharina Mascherbauer, Kseniya Halavina, Gregor Heitzinger, Carolina Dona, Varius Dannenberg, Georg Spinka, Matthias Koschutnik, Martin Andreas, Christian Hengstenberg, Philipp E Bartko
BACKGROUND: Transcatheter aortic valve replacement (TAVR) revolutionized the therapy of severe aortic stenosis (AS) with rising numbers. Mixed aortic valve disease (MAVD) treated by TAVR is gaining more interest, as those patients represent a more complex cohort as compared to isolated AS. However, concerning long-term outcome for this cohort only limited data is available. AIMS: To assess the prevalence of MAVD in TAVR patients, investigate its association with paravalvular regurgitation (PVR), and analyse its impact on long-term mortality after TAVR...
January 17, 2024: European Heart Journal Cardiovascular Imaging
https://read.qxmd.com/read/38204550/first-in-human-treatment-of-severe%C3%A2-tricuspid-regurgitation-using-a-novel%C3%A2-cross-caval-heterotopic-device
#33
JOURNAL ARTICLE
Antonio Sisinni, Rodrigo Estévez-Loureiro, Berenice Caneiro-Queija, Manuel Barreiro-Pérez, Jose A Baz, Pablo Pazos, Rocio Gonzalez-Ferreiro, Andrés Iñiguez-Romo
A 79-year-old woman, previously surgically treated for mitral and aortic valve replacement, experienced recurrent torrential tricuspid regurgitation after 2 transcatheter edge-to-edge repair procedures. Heart team assessment deemed the patient high risk for redo surgery and excluded transcatheter edge-to-edge repair and orthotopic replacement. The patient was then scheduled for a novel cross-caval device implantation.
December 20, 2023: JACC. Case reports
https://read.qxmd.com/read/38192270/heart-transplantation-using-a-donor-heart-with-repaired-tetralogy-of-fallot-a-case-report
#34
Takura Taguchi, Daisuke Yoshioka, Koichi Toda, Shigeru Miyagawa
BACKGROUND: Heart transplantation is the gold standard therapy for end-stage heart failure; however, it is limited by a shortage of available donors. In recent years, heart transplantations have been performed using marginal donor hearts with valvular and/or congenital cardiac abnormalities. CASE SUMMARY: A 60-year-old woman with acromegalic cardiomyopathy underwent left ventricular assist device implantation and aortic valve (AV) closure 4 years prior. After 2 months, repeat AV closure and omental flap transposition were performed...
January 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38161949/an-incidental-finding-of-libman-sacks-endocarditis-%C3%A2-in-a-young-female-with-systemic-lupus-erythematosus-who-presented-with-pleuritic-chest-pain
#35
Ali T Alhashem, Walaa M Hassan
Libman-Sacks endocarditis (LSE) is a rare disease found incidentally in ‎postmortem autopsies, characterized by microscopic to large ‎verrucous vegetation on the cardiac valves, the most affected site is ‎the mitral valve followed by the aortic valve. Females of reproductive age ‎were observed as the most affected individuals as found in studies. ‎Most individuals with LSE are asymptomatic and ‎generally discovered lately when they presented with ‎thromboembolic disorders such as stroke, cognitive disabilities, and death...
November 2023: Curēus
https://read.qxmd.com/read/38111895/editorial-transcatheter-mitral-and-tricuspid-valve-therapies
#36
EDITORIAL
Omar Chehab, Ronak Rajani, Simon Redwood, Bernard Prendergast, Tiffany Patterson
No abstract text is available yet for this article.
2023: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38084191/challenges-of-management-of-subaortic-membrane-in-a-young-adult-patient-a-case-report
#37
Talal Asif, Lucas A Georger, Krish Sardesai, Maya Kosinska, Muhammad Shah Miran
This article presents a case review and literature review focused on the challenges of managing subaortic membranes (SAMs) in young adult patients with mild aortic regurgitation (AR) or aortic stenosis (AS). The study aims to discuss the diagnosis of SAM, the imaging studies used for assessment, the management strategies in young patients, the risk of valvular damage, and the controversy surrounding prophylactic resection in mild AR. The management of SAM in adults poses challenges due to limited treatment options and potential complications, necessitating further investigation into the progression of AS and AR in asymptomatic SAM patients...
November 2023: Curēus
https://read.qxmd.com/read/38073974/a-complex-case-of-infective-endocarditis-with-systemic-embolization-multidisciplinary-approach-to-diagnosis-and-management
#38
Mafalda Vasconcelos, Isabel Cardoso, Alberto Fior, Ana Paiva Nunes
A 44-year-old man with no known medical history presented with stroke symptoms and was found to have occlusion of the M1 segment of the right middle cerebral artery. Thrombolysis and aspiration thrombectomy were successfully performed. However, in the following hours, he developed a fever and multiple cerebral hemorrhages. Due to a drop in hemoglobin post-angiography, an abdominopelvic CT was performed, revealing extensive splenic and renal infarctions. The patient was diagnosed with infective endocarditis (IE) with mitral and aortic vegetations and severe aortic regurgitation...
November 2023: Curēus
https://read.qxmd.com/read/38056954/-early-structural-valve-deterioration-of-trifecta-aortic-bioprosthesis-report-of-a-case
#39
JOURNAL ARTICLE
Keita Tanaka, Toshihiko Suzuki, Jotaro Kobayashi, Takashi Yasukawa
Trifecta, an externally mounted bovine pericardial bioprosthetic aortic valve, provides excellent hemodynamic performance;however, early structural deterioration of this valve has been reported. A 60-year-old man with progressive dyspnea was admitted to the emergency unit of our institution. Seven years prior, he underwent aortic valve replacement with 23-mm Trifecta valve. Severe aortic valve regurgitation and stenosis due to structural valve deterioration was diagnosed and redo aortic valve replacement using an Inspiris valve was performed...
October 2023: Kyobu Geka. the Japanese Journal of Thoracic Surgery
https://read.qxmd.com/read/38054086/surgical-treatment-of-behcet-s-disease-with-severe-aortic-regurgitation
#40
REVIEW
Chuanbin Tang, Yu Song, Xiaofan Huang, Yuanming Li, Yisilamujiang Tuerxun, Xingjian Hu, Huadong Li, Long Wu
Behcet's disease (BD) is a multisystem inflammatory disease that is characterized by oral aphthosis, genital aphthosis, ocular lesions, and cutaneous lesions. Although BD rarely affects the cardiovascular system, its symptoms can be shown as aortic regurgitation (AR), which requires surgical intervention. Due to the special pathogenesis of BD, a low preoperative diagnosis rate and a high incidence of serious complications, such as perivalvular leakage, valve detachment, and pseudoaneurysm after prosthetic valve replacement, surgical treatment of BD with severe AR has a poor prognosis...
2023: Frontiers in Cardiovascular Medicine
keyword
keyword
84997
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.